• Markets
    • icon
  • Companies
HMD · ASX

HeraMED Ltd. (ASX:HMD)

AU$0.04

 0.0 (0.0%)
ASX:Live
05/12/2023 03:29:38 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HMD Overview

HMD Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About HMD

Website

HeraMED Ltd.

Telephone

N/A

Address

Description

N/A

HMD Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.03 - 0.16

Trade Value (12mth)

AU$3,727.00

1 week

8.11%

1 month

0%

YTD

-68%

1 year

-69.23%

All time high

0.335

Key Fundamentals

EPS 3 yr Growth

-35.400%

EBITDA Margin

%

Operating Cashflow

-$4m

Free Cash Flow Return

-181.30%

ROIC

-345.60%

Interest Coverage

-1.60

Quick Ratio

3.60

Other Data

Shares on Issue (Fully Dilluted)

243m

HALO Sector

Technology

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

HMD Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

31 May 21

Results of Annual General Meeting

×

Results of Annual General Meeting

31 July 23

New Appointments to Strengthen USA Commercialisation

×

New Appointments to Strengthen USA Commercialisation

31 July 23

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

31 January 23

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

31 January 22

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

31 August 22

Application for quotation of securities - HMD

×

Application for quotation of securities - HMD

31 August 22

Cleansing Notice

×

Cleansing Notice

30 May 23

Results of Annual General Meeting

×

Results of Annual General Meeting

29 May 19

Results of Annual General Meeting

×

Results of Annual General Meeting

29 March 22

Annual Report to shareholders

×

Annual Report to shareholders

29 March 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 March 21

Annual Report to shareholders

×

Annual Report to shareholders

29 March 19

Annual Report

×

Annual Report

29 July 22

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

29 December 22

Notice of General Meeting

×

Notice of General Meeting

29 April 22

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

29 April 22

Application for quotation of securities - HMD

×

Application for quotation of securities - HMD

29 April 22

Cleansing Notice

×

Cleansing Notice

29 April 21

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 October 22

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

28 July 22

HMD & e-Lovu Health Partnership for HeraCARE Deployment US

×

HMD & e-Lovu Health Partnership for HeraCARE Deployment US

28 January 22

Application for quotation of securities - HMD

×

Application for quotation of securities - HMD

28 January 22

Cleansing Notice

×

Cleansing Notice

28 February 23

Appendix 4E & Preliminary Final Report

×

Appendix 4E & Preliminary Final Report

28 April 23

Quarterly Activities & Cashflow Report

×

Quarterly Activities & Cashflow Report

28 April 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

27 March 23

Change of Director's Interest Notice

×

Change of Director's Interest Notice

HMD Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.04 -0.04 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.04 -0.04 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.8 -12.4 24.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.03 -0.02 -0.01 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock 28.0 12.2 43.8 Lock Lock Lock
     Yield % Lock Lock Lock Lock -29.2 -10.3 -13.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.02 -0.00 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 -0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.4 -163.6 295.3 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 126 175 214 Lock Lock Lock
Basic m Lock Lock Lock Lock 126 175 214 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -72.6 101.1 173.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 5 5 4 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.1 16.9 -3.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -634.5 -262.3 -99.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 735 362 199 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -5 -5 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.9 -5.4 16.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -8,078.6 -4,232.1 -1,289.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -5 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.9 -4.7 12.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -8,733.2 -4,545.7 -1,453.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -8 -7 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -5 -8 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.4 -55.9 7.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock -8,500.3 -6,588.2 -2,229.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -4 -4 -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 -1 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 4 7 4 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -4 -4 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.8 -7.1 14.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -70.4 -37.5 -11.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 5 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 4 6 6 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -2 0 -4 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 6 1 Lock Lock Lock
Equity $m Lock Lock Lock Lock 3 0 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 3 0 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -22.3 -105.2 2,994.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -117.9 -120.5 -114.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -188.4 5,217.7 -166.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -152.4 -142.0 -101.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -150.7 -566.7 -345.6 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -124.7 -320.8 -181.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Leverage
Interest Cover X Lock Lock Lock Lock -309.2 -2.2 -1.6 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.5 0.0 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -85.7 133.0 -85.2 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.3 0.9 3.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.1 0.9 3.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 86.3 91.5 86.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -603.8 -75.5 -317.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.2 0.9 1.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 4.9 4.0 3.4 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 N/A 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 449.5 329.8 99.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.1 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -8,500.3 -6,588.2 -2,229.5 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -117.9 -120.5 -114.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -117.9 -120.5 -114.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.6 -43.3 1.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -188.4 5,217.7 -166.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -188.4 5,217.7 -166.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 74.6 92.3 108.5 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 1,503.8 401.4 191.6 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 1,578.4 493.7 300.1 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 162.3 258.9 166.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 1,416.1 234.8 133.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

HMD Shortsell

Frequently Asked Questions

The current share price of HeraMED Ltd. (HMD:ASX) is AU$0.04.
The 52-week high share price for HeraMED Ltd. (HMD:ASX) is AU$0.16.
The 52-week low share price for HeraMED Ltd. (HMD:ASX)? is AU$0.03.
HeraMED Ltd. (HMD:ASX) does not pay a dividend.
HeraMED Ltd. (HMD:ASX) does not pay a dividend.
HeraMED Ltd. (HMD:ASX) does not offer franking credits.
HeraMED Ltd. (HMD:ASX) is classified in the Technology.
The current P/E ratio for HeraMED Ltd. (HMD:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.